[Interstitial lung diseases].
Interstitial lung diseases (ILD) are an heterogeneous group of inflammatory diseases characterized by an anatomical distortion of peripheral airways and interstitium, determined by a first stage of alveolitis and a following stage of fibrosis. Natural history of several ILD is characterized by slow and progressive destruction of alveolar-capillary functional units, often with respiratory failure and death. For their smoldering evolution and not specificity of symptoms (exertional dyspnea and cough) ILD may remain not diagnosed and not treated for a long time.
Mazzoccoli
Gianluigi
G
Divisione di Medicina Interna, IRCCS Casa Sollievo della Sofferenza, Opera di Padre Pio da Pietrelcina, San Giovanni Rotondo. g.mazzoccoli@tin.it
Carughi
Stefano
S
De Cata
Angelo
A
Giuliani
Antonio
A
Masciale
Nunzia
N
La Viola
Marco
M
Puzzolante
Felice
F
Balzanelli
Mario
M
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D019867:Anti-Glomerular Basement Membrane Disease / Q000628:therapy; D001706:Biopsy; D001999:Bronchoscopy; D018549:Cryptogenic Organizing Pneumonia / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology; D017563:Lung Diseases, Interstitial / Q000145:classification / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000473:pathology / Q000628:therapy; D016040:Lung Transplantation; D008875:Middle Aged; D010956:Plasmapheresis; D013902:Radiography, Thoracic; D011877:Radionuclide Imaging; D012129:Respiratory Function Tests; D012307:Risk Factors; D017565:Sarcoidosis, Pulmonary / Q000628:therapy; D014057:Tomography, X-Ray Computed
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents